ArticleCancer medicine2025

A Real-Word Analysis of the Correlation Between Clinical Efficacy and Predictive Factors of Immune-Related Adverse Events in Patients With Nonsmall Lung Cancer Treated With Nivolumab Plus Ipilimumab.

Atsuto Mouri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.